Hybridoma Detail
Hybridoma Collection: 2H6-C2
| Catalogue No.: | 95022203 |
|---|---|
| Cell Line Name: | 2H6-C2 |
| Reactivity: | Anti- bovine herpes virus 1 (BHV-1) |
| Antibody Isotype: | IgG2b |
| Fusion Species: | Mouse x Mouse Hybridoma |
| Myeloma: | Sp2/0 |
| Immunological Donor: | BALB/c mouse spleen |
| Immunogen: | Bovine Herpes virus 1 |
| Transfected DNA: | Not Applicable |
| Cell Line Description: | The antibody is directed against an immunodominant glycoprotein of bovine herpes 1 BHV-1 (infectious rhinotracheitis virus). |
| Application: | In vitro potency testing of BHV-1 vaccines. |
| Sub Culture Routine: | Maintain cultures between 100,000 - 1,000,000 cells/ml; 5% CO2; 37°C. |
| Culture Medium: | DMEM + 2mM glutamine + 2 5% Foetal Bovine Serum (FBS) + 5% Horse Serum (HS) |
| Depositor: | Obtained from ATCC |
| Originator: | No |
| Country: | USA |
| References: | 69th Conf Res Workers Anim Dis 1987; p54. |
| Patent: | None Specified by Depositor |
| Research Council Deposit: | No |
| Release Conditions: | No |
The HPA Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by HPA Culture Collections are accurate, HPA Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and HPA Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.
Cultures supplied by HPA Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.
